Literature DB >> 7370984

Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity.

L L Wotring, J L Roti Roti.   

Abstract

The delayed cytotoxic effect of 6-thioguanine (TG) was studied using L1210 mouse leukemic cells in culture. The cell cycle distribution of a population treated continuously with 10(-5) M TG was compared to that of control cells using flow cytometric analysis. The TG-treated cells had an increase in the fraction of the population in G2-M, a decrease in G1, and a constant level in S phase. However, the [methyl-3H]thymidine-labeling index decreased dramatically during TG treatment. Thus, it appeared that some cells were arrested in S phase and that G1 cells did not enter S phase, due to failure to synthesize DNA. To examine the importance of the G2 and S cell progression blocks, cells were exposed to a lethal treatment of 10(-5) M TG for 12 hr and returned to normal medium. Under these conditions, the fraction of the population in both S and G1 decreased, and nearly one-half of the cells accumulated in G2 by 60 hr after TG addition, compared to a G2 fraction of less than one-tenth for the control cells. These results showed that the delayed cytotoxic effect of TG was associated with a cell progression block in the second G2 phase after TG addition, whereas the retention of cells in S phase appeared to be due to readily reversible secondary effects of TG.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370984

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.

Authors:  D H Shevrin; L J Kilton; T E Lad; M Mullane; B Esparaz; R Knop; J Egner; P Johnson; R Blough; S French
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

2.  Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor.

Authors:  B F Pan; T S Priebe; J A Nelson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Effect of 6-thioguanine on Chlamydia trachomatis growth in wild-type and hypoxanthine-guanine phosphoribosyltransferase-deficient cells.

Authors:  B Qin; G McClarty
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

4.  Genome-based discovery and total synthesis of janustatins, potent cytotoxins from a plant-associated bacterium.

Authors:  Reiko Ueoka; Philipp Sondermann; Stefan Leopold-Messer; Yizhou Liu; Rei Suo; Agneya Bhushan; Lida Vadakumchery; Ute Greczmiel; Yoko Yashiroda; Hiromi Kimura; Shinichi Nishimura; Yojiro Hoshikawa; Minoru Yoshida; Annette Oxenius; Shigeki Matsunaga; R Thomas Williamson; Erick M Carreira; Jörn Piel
Journal:  Nat Chem       Date:  2022-09-05       Impact factor: 24.274

5.  6-Thioguanine: high-dose 2-H infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; M B van Leeuwen; J M van Baal; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

6.  Mechanism by which caffeine potentiates lethality of nitrogen mustard.

Authors:  C C Lau; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Cloning and sequence analysis of the Saccharomyces cerevisiae RAD9 gene and further evidence that its product is required for cell cycle arrest induced by DNA damage.

Authors:  R H Schiestl; P Reynolds; S Prakash; L Prakash
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

8.  6-mercaptopurine: high-dose 24-h infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; J M van Baal; M B van Leeuwen; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

9.  Prediction of thioguanine-induced cytotoxicity by dual-parameter flow cytometric analysis.

Authors:  J Maybaum; P Ting; C E Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 10.  The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.

Authors:  A C Sartorelli
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.